Previous work by Peelen et al. showed upregulated gene expression of the NLRP3 inflammasome components including NLRP3, caspase-1, and IL-1β in PBMCs from RRMS patients in comparison to the control group [18]. This evidence concerns the gene CASP1 and relapsing-remitting multiple sclerosis.